Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-05-14 Purchase |
2020-05-18 4:15 pm |
Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Director |
13,986 | $1.43 | $20,000 | 18,875 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-10 Other |
2021-06-14 4:10 pm |
N/A 2023-06-10 |
Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Former Director Director |
473,468 | $0 | 3,345,090 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-20 4:33 pm |
2022-05-18 2031-05-18 |
Hepion Pharmaceuticals Inc. | HEPA | ADAMS THOMAS PHD Director |
200,000 | $0 | 291,050 (Direct) |
View |
| 2020-08-19 Option Award |
2020-08-21 4:16 pm |
2021-08-19 2030-08-19 |
Hepion Pharmaceuticals Inc. | HEPA | ADAMS THOMAS PHD Director |
30,000 | $0 | 91,050 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
N/A 2030-06-17 |
Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Executive Chairman |
173,145 | $0 | 477,870 (Direct) |
View |